| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Hui Pan, Ai-Ling Tian, Fréderic Castinetti, Isabelle Martins, Oliver Kepp, Guido Kroeme. Autophagy-dependent hepatocyte secretion of DBI/ACBP induced by glucocorticoids determines the pathogenesis of cushing syndrome. Autophagy. 2024-12-12. PMID:39663572. |
prolonged increase in glucocorticoid concentrations causes an extreme form of metabolic syndrome, dubbed "cushing syndrome", which is characterized by clinical features including hyperphagia, hyperdipsia, dyslipidemia, hyperinsulinemia, insulin resistance, lipodystrophy, visceral adiposity, steatosis, sarcopenia and osteoporosis. |
2024-12-12 |
2024-12-14 |
mouse |
| Enaya Tufail, Somali Sanyal, Ambrish Mithal, Sabyasachi Sanyal, Naibedya Chattopadhya. The role of glucagon-like peptides in osteosarcopenia. The Journal of endocrinology. 2024-12-10. PMID:39656031. |
various metabolic abnormalities including obesity, insulin resistance, hypertension, dyslipidemia, hyperthyroidism, and low vitamin d levels have been linked to both osteopenia and sarcopenia. |
2024-12-10 |
2024-12-12 |
Not clear |
| Mustafa Tuna, Bilgehan Kolutek Ay, Hatice Incebiyi. Are Hyperlipidaemia and Insulin Resistance Risks For Sarcopenia? Journal of the College of Physicians and Surgeons--Pakistan : JCPSP. vol 34. issue 12. 2024-12-09. PMID:39648382. |
are hyperlipidaemia and insulin resistance risks for sarcopenia? |
2024-12-09 |
2024-12-11 |
Not clear |
| Mustafa Tuna, Bilgehan Kolutek Ay, Hatice Incebiyi. Are Hyperlipidaemia and Insulin Resistance Risks For Sarcopenia? Journal of the College of Physicians and Surgeons--Pakistan : JCPSP. vol 34. issue 12. 2024-12-09. PMID:39648382. |
to investigate whether insulin resistance and lipid metabolism disorders could be associated with sarcopenia. |
2024-12-09 |
2024-12-11 |
Not clear |
| Jessica A Alvarez, Chin-An Yang, Victoria Ojuri, Kahsavyah Buckley, Brahmchetna Bedi, Joffi Musonge-Effoe, Adaiah Soibi-Harry, Cecile D Lahir. Sex Differences in Metabolic Disorders of Aging and Obesity in People with HIV. Current HIV/AIDS reports. vol 22. issue 1. 2024-11-21. PMID:39570329. |
the purpose of this review is to summarize recent research assessing sex differences in metabolic disorders among pwh, including weight gain/obesity, steatotic liver disease, insulin resistance/diabetes, dyslipidemia, bone loss/osteoporosis, and sarcopenia. |
2024-11-21 |
2024-11-23 |
Not clear |
| Raniah I Alnaser, Fawaz A Alassaf, Mohammed N Abe. Incretin-Based Therapies: A Promising Approach for Modulating Oxidative Stress and Insulin Resistance in Sarcopenia. Journal of bone metabolism. 2024-11-04. PMID:39496297. |
incretin-based therapies: a promising approach for modulating oxidative stress and insulin resistance in sarcopenia. |
2024-11-04 |
2024-11-07 |
Not clear |
| Raniah I Alnaser, Fawaz A Alassaf, Mohammed N Abe. Incretin-Based Therapies: A Promising Approach for Modulating Oxidative Stress and Insulin Resistance in Sarcopenia. Journal of bone metabolism. 2024-11-04. PMID:39496297. |
recent studies have linked sarcopenia development to the hallmarks of diabetes, oxidative stress, and insulin resistance. |
2024-11-04 |
2024-11-07 |
Not clear |
| Raniah I Alnaser, Fawaz A Alassaf, Mohammed N Abe. Incretin-Based Therapies: A Promising Approach for Modulating Oxidative Stress and Insulin Resistance in Sarcopenia. Journal of bone metabolism. 2024-11-04. PMID:39496297. |
the anti-oxidant and insulin sensitivityenhancing effects of incretin-based therapies may provide a promising option for the treatment of sarcopenia. |
2024-11-04 |
2024-11-07 |
Not clear |
| Raniah I Alnaser, Fawaz A Alassaf, Mohammed N Abe. Incretin-Based Therapies: A Promising Approach for Modulating Oxidative Stress and Insulin Resistance in Sarcopenia. Journal of bone metabolism. 2024-11-04. PMID:39496297. |
this review aimed to unveil the role of oxidative stress and insulin resistance in the pathogenesis of sarcopenia and explore the potential benefits of incretin-based therapies in individuals with sarcopenia. |
2024-11-04 |
2024-11-07 |
Not clear |
| Zihao Zhang, Xin Chen, Na Jian. The triglyceride glucose related index is an indicator of Sarcopenia. Scientific reports. vol 14. issue 1. 2024-10-15. PMID:39406884. |
the triglyceride glucose (tyg) related index, a metric used to evaluate assessing insulin resistance (ir), has received limited attention in its association with sarcopenia. |
2024-10-15 |
2024-10-18 |
human |
| Canhui Guo, Ling He, Yansong Tu, Chunyan Xu, Caifeng Liao, Hurong Lai, Chuyang Lin, Huaijun T. Insulin resistance and sarcopenia: a prognostic longitudinal link to stroke risk in middle-aged and elderly Chinese population. BMC public health. vol 24. issue 1. 2024-10-10. PMID:39385146. |
insulin resistance and sarcopenia: a prognostic longitudinal link to stroke risk in middle-aged and elderly chinese population. |
2024-10-10 |
2024-10-12 |
Not clear |
| Canhui Guo, Ling He, Yansong Tu, Chunyan Xu, Caifeng Liao, Hurong Lai, Chuyang Lin, Huaijun T. Insulin resistance and sarcopenia: a prognostic longitudinal link to stroke risk in middle-aged and elderly Chinese population. BMC public health. vol 24. issue 1. 2024-10-10. PMID:39385146. |
insulin resistance (ir) and sarcopenia are both closely associated with metabolic diseases. |
2024-10-10 |
2024-10-12 |
Not clear |
| Minghui Li, Rong Ji, Xi Liu, Yongjian W. Associations of metabolic syndrome and its components with sarcopenia, and the mediating role of insulin resistance: Findings from NHANES database. BMC endocrine disorders. vol 24. issue 1. 2024-10-01. PMID:39350099. |
associations of metabolic syndrome and its components with sarcopenia, and the mediating role of insulin resistance: findings from nhanes database. |
2024-10-01 |
2024-10-03 |
Not clear |
| Minghui Li, Rong Ji, Xi Liu, Yongjian W. Associations of metabolic syndrome and its components with sarcopenia, and the mediating role of insulin resistance: Findings from NHANES database. BMC endocrine disorders. vol 24. issue 1. 2024-10-01. PMID:39350099. |
to investigate the association between metabolic syndrome (mets) and its components with sarcopenia, and to explore the extent to which insulin resistance (ir) mediates this association, using data from the national health and nutrition examination survey (nhanes). |
2024-10-01 |
2024-10-03 |
Not clear |
| Ayumi Toba, Joji Ishikaw. Sarcopenia as a risk factor for hypertension. Hypertension research : official journal of the Japanese Society of Hypertension. 2024-09-19. PMID:39300297. |
insulin resistance, oxidative stress, imbalance of catabolism and anabolism, and chronic inflammation are the underlying mechanisms that explain the association between hypertension and sarcopenia. |
2024-09-19 |
2024-09-22 |
Not clear |
| Syeda Roohina Ali, Augustine Nkembo, Srinivas M Tipparaju, Muhammad Ashraf, Xuan Wanlin. Sarcopenia: Recent Advances for Detection, Progression and Metabolic Alterations along with Therapeutic Targets. Canadian journal of physiology and pharmacology. 2024-08-26. PMID:39186818. |
in addition, the review provides insights regarding lipid metabolism on sarcopenia, with an emphasis on the effects of inflammation and insulin resistance. |
2024-08-26 |
2024-08-30 |
Not clear |
| Ismail Taskent, Bunyamin Ece, Sonay Aydi. Assessment of Psoas Muscle Index in Middle-Aged Type 2 Diabetes Patients: Impact of Insulin Therapy on Sarcopenia. Tomography (Ann Arbor, Mich.). vol 10. issue 7. 2024-07-26. PMID:39058051. |
assessment of psoas muscle index in middle-aged type 2 diabetes patients: impact of insulin therapy on sarcopenia. |
2024-07-26 |
2024-07-28 |
Not clear |
| Ismail Taskent, Bunyamin Ece, Sonay Aydi. Assessment of Psoas Muscle Index in Middle-Aged Type 2 Diabetes Patients: Impact of Insulin Therapy on Sarcopenia. Tomography (Ann Arbor, Mich.). vol 10. issue 7. 2024-07-26. PMID:39058051. |
the relationship between sarcopenia and insulin resistance suggests insulin therapy's potential in preserving muscle mass, particularly in type 2 diabetes mellitus (t2dm) patients. |
2024-07-26 |
2024-07-28 |
Not clear |
| Jiju Yang, Cong Liu, Sihao Zhao, Lixiang Wang, Guanwei Wu, Ziyi Zhao, Chungen L. The association between the triglyceride-glucose index and sarcopenia: data from the NHANES 2011-2018. Lipids in health and disease. vol 23. issue 1. 2024-07-19. PMID:39030624. |
the triglyceride-glucose (tyg) index is a marker of insulin resistance, but its role in sarcopenia is controversial. |
2024-07-19 |
2024-07-22 |
Not clear |
| Luning Yang, Di Liu, Shide Jiang, Hengzhen Li, Lin Chen, Yuxiang Wu, Anko Elijah Essien, Michael Opoku, Shinen Naranmandakh, ShuGuang Liu, Qin Ru, Yusheng L. SIRT1 signaling pathways in sarcopenia: Novel mechanisms and potential therapeutic targets. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. vol 177. 2024-06-22. PMID:38908209. |
sirt1 functioned as an important role in the occurrence and progression of sarcopenia through regulating key pathways related to protein homeostasis, apoptosis, mitochondrial dysfunction, insulin resistance and autophagy in skeletal muscle, including sirt1/forkhead box o (foxo), amp-activated protein kinase (ampk)/sirt1/nuclear factor κb (nf-κb), sirt1/p53, ampk/sirt1/peroxisome proliferator-activated receptor gamma coactivator-1α (pgc-1α), and sirt1/live kinase b1 (lkb1)/ampk pathways. |
2024-06-22 |
2024-06-25 |
human |